Elena I. Shramova

16/10 Miklukho Maklaya Street
Moscow, MOW 117997, Russian Federation

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

Multifunctional theranostic nanoplatform based on HER2-specific liposomes loaded with IR783 for simultaneous PTT/PDT therapy and optical bioimaging.

Multifunctional theranostic nanoplatform based on HER2-specific liposomes loaded with IR783 for simultaneous PTT/PDT therapy and optical bioimaging.

Journal: Nanomedicine : nanotechnology, biology, and medicine

Published: March 12, 2026

Pre-Treatment with Dacarbazine Sensitizes B16 Melanoma to CAR T Cell Therapy in Syngeneic Mouse Model.

Pre-Treatment with Dacarbazine Sensitizes B16 Melanoma to CAR T Cell Therapy in Syngeneic Mouse Model.

Journal: International journal of molecular sciences

Published: October 24, 2025

A Syngenic Mouse Model of Breast Cancer Expressing Human ERBB2 and NanoLuc Luciferase Genes.

A Syngenic Mouse Model of Breast Cancer Expressing Human ERBB2 and NanoLuc Luciferase Genes.

Journal: Doklady. Biochemistry and biophysics

Published: July 04, 2025

Bispecific targeting system based on DARPins-modified light-chain ferritin for cancer chemotherapy.

Bispecific targeting system based on DARPins-modified light-chain ferritin for cancer chemotherapy.

Journal: Biochimie

Published: July 03, 2025

Targeted Nanoliposomes for the Delivery of Boronophenylalanine into HER2-Positive Cells.

Targeted Nanoliposomes for the Delivery of Boronophenylalanine into HER2-Positive Cells.

Journal: Acta naturae

Published: June 17, 2025

The Impact of the Protein-Opener of the Desmoglein Contacts on the Accumulation of Targeted Nanoagents in HER2-Positive Solid Tumors.

The Impact of the Protein-Opener of the Desmoglein Contacts on the Accumulation of Targeted Nanoagents in HER2-Positive Solid Tumors.

Journal: Doklady. Biochemistry and biophysics

Published: May 25, 2025

Genetically modified NK cells equipped with a switchable CAR for the treatment of HER2-positive cancers.

Genetically modified NK cells equipped with a switchable CAR for the treatment of HER2-positive cancers.

Journal: Biochimie

Published: May 22, 2025

Fusion of SARS-CoV-2 neutralizing LCB1 peptide with Bacillus amyloliquefaciens RNase improves antiviral efficacy.

Fusion of SARS-CoV-2 neutralizing LCB1 peptide with Bacillus amyloliquefaciens RNase improves antiviral efficacy.

Journal: Scientific reports

Published: March 29, 2025

Intravital Optical Bioimaging of Ovarian Cancer Using a Luminescent Cell Line.

Intravital Optical Bioimaging of Ovarian Cancer Using a Luminescent Cell Line.

Journal: Doklady. Biochemistry and biophysics

Published: February 25, 2025

Targeted Therapy in Combination with an Agent That Enhances Terminal Differentiation of Cancer Cells.

Targeted Therapy in Combination with an Agent That Enhances Terminal Differentiation of Cancer Cells.

Journal: Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections

Published: November 11, 2024

Combination with a Low Dose of Doxorubicin Further Boosts the Antitumor Effect of SLURP-1 In Vivo and Associates with EGFR Down-Regulation.

Combination with a Low Dose of Doxorubicin Further Boosts the Antitumor Effect of SLURP-1 In Vivo and Associates with EGFR Down-Regulation.

Journal: Acta naturae

Published: September 30, 2024

A novel HER2-specific sensor based on DARPin_9-29 and albumin binding domain for real-time fluorescence-guided tumor detection in animal model of cancer.

A novel HER2-specific sensor based on DARPin_9-29 and albumin binding domain for real-time fluorescence-guided tumor detection in animal model of cancer.

Journal: Biochemical and biophysical research communications

Published: September 14, 2024

Showing 1-12 of 35

Last Updated: 09/26/2026